Serum fructosamine in diabetic pregnancy

Area of Science:

• Clinical Chemistry
• Endocrinology
• Reproductive Medicine

Background:

• Serum fructosamine is a marker for glycemic control.
• Pregnancy and diabetes can affect fructosamine levels.
• Understanding fructosamine in pregnancy is crucial for managing diabetes.

Purpose of the Study:

• To evaluate serum fructosamine concentrations in various pregnant subgroups and non-pregnant hyperglycemic individuals.
• To compare fructosamine levels between pregnant women and healthy controls.
• To assess the correlation between serum fructosamine and plasma glucose in different populations.

Main Methods:

• Serum fructosamine levels were measured in blood donors, normal pregnant subjects, gestational diabetics (insulin and diet-treated), established diabetics, and hyperglycemic non-pregnant subjects.
• Statistical analysis was performed to compare groups and assess correlations.

Main Results:

• Mean serum fructosamine in pregnant subgroups did not exceed that of blood donors.
• Normal pregnant subjects showed decreased fructosamine with gestational age and increased levels with maternal age.
• Hyperglycemic non-pregnant subjects had significantly elevated fructosamine, with 96% exceeding the donor upper limit.
• A strong correlation between serum fructosamine and preprandial plasma glucose was found in hyperglycemic subjects.

Conclusions:

• Serum fructosamine is a reliable indicator of hyperglycemia in non-pregnant individuals.
• Fructosamine levels in pregnant women, even with diabetes, remained within or below donor ranges.
• Gestational age and maternal age influence fructosamine levels in normal pregnancy.